Respirology

Guaifenesin Non-prescription in Your Practice

Guaifenesin is a mucoactive agent that provides symptomatic management of chest congestion and cough associated with acute upper respiratory tract infections (URTIs). This accredited program reviews the purpose of mucus in a healthy respiratory system, and what happens when hypersecretion or mucus dysfunction occurs. Guaifenesin increases hydration of airway mucus, increases the volume of bronchial secretions and decreases mucus viscosity, which enhances clearance by promoting more effective expectoration.

Two case studies highlight key features of guaifenesin including indications, dosing and frequency. The impact of COVID-19 on counseling customers with respiratory symptoms is also addressed.

DURATION

30 min

PROFESSION

Pharmacy

# OF CREDITS

1.25

ACCREDITATION

CCCEP

EXPIRY DATE

2025-01-25

Guaifenesin is a mucoactive agent that provides symptomatic management of chest congestion and cough associated with acute upper respiratory tract infections (URTIs). This accredited program reviews the purpose of mucus in a healthy respiratory system, and what happens when hypersecretion or mucus dysfunction occurs. Guaifenesin increases hydration of airway mucus, increases the volume of bronchial secretions and decreases mucus viscosity, which enhances clearance by promoting more effective expectoration.

Two case studies highlight key features of guaifenesin including indications, dosing and frequency. The impact of COVID-19 on counseling customers with respiratory symptoms is also addressed.


This program has received an unrestricted educational grant or in-kind support from RB Health (Canada) Inc.

Faculty

Carole Dion, BSc Pharm

Kelly Haggerty, BSc Pharm, RPh, NCMP, ISTM, CTH

Ali Reza Ladak, Bsc Pharm, RPh

Learning objectives

Upon completion of this continuing education program, participants will be better able to:

  • Describe how guaifenesin works as a mucoactive agent to relieve congestion associated with common colds and upper respiratory tract infections;
  • Identify the approved indications for guaifenesin and supporting data;
  • Determine the dosage best suited for individuals experiencing cough and congestion from the common cold and flu;
  • Discuss the use of multi-symptom products for temporary relief from chest, nasal and sinus congestion, headache, sore throat, and minor aches and pains.

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.25 CEUs.  

CCCEP File Number: 1066-2022-3550-I-P.

Cost of course:  
Free
# of credits: 1.25
Duration: 30 min

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

Guaifenesin Non-prescription in Your Practice

30 min

Duration

Pharmacy

Profession

1.25

# of credits

Learning Objectives

Upon completion of this continuing education program, participants will be better able to:

  • Describe how guaifenesin works as a mucoactive agent to relieve congestion associated with common colds and upper respiratory tract infections;
  • Identify the approved indications for guaifenesin and supporting data;
  • Determine the dosage best suited for individuals experiencing cough and congestion from the common cold and flu;
  • Discuss the use of multi-symptom products for temporary relief from chest, nasal and sinus congestion, headache, sore throat, and minor aches and pains.

CCCEP
Accredited
Course

CCCEP

ACCREDITATION

Respirology

Learning Category

Medication

Topic

0

Price

2025-01-25

Expiry Date

CAN-eng

Region/Language

Course Description

Guaifenesin is a mucoactive agent that provides symptomatic management of chest congestion and cough associated with acute upper respiratory tract infections (URTIs). This accredited program reviews the purpose of mucus in a healthy respiratory system, and what happens when hypersecretion or mucus dysfunction occurs. Guaifenesin increases hydration of airway mucus, increases the volume of bronchial secretions and decreases mucus viscosity, which enhances clearance by promoting more effective expectoration.

Two case studies highlight key features of guaifenesin including indications, dosing and frequency. The impact of COVID-19 on counseling customers with respiratory symptoms is also addressed.


This program has received an unrestricted educational grant or in-kind support from RB Health (Canada) Inc.

Faculty

Carole Dion, BSc Pharm

Kelly Haggerty, BSc Pharm, RPh, NCMP, ISTM, CTH

Ali Reza Ladak, Bsc Pharm, RPh

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.25 CEUs.  

CCCEP File Number: 1066-2022-3550-I-P.